Zhejiang Jingxin Pharmaceutical Co., Ltd
Independent Director 20 25 Annual Debriefing Report As Zhejiang Jingxin Pharmaceutical Co., Ltd. （ hereinafter referred to as “ Company ") Independent Director , Root According to " Corporate Law 》 《 Governance Guidelines for Listed Companies 》 《 Guidelines for Self-Regulatory Guidelines for Listed Companies on the Shenzhen Stock Exchange No. 1 —— Standardized Operation of Listed Companies on the Main Board", "Measures for the Administration of Independent Directors of Listed Companies" and other relevant laws, Regulations and Articles of Association 》 "Independent Director Work System" " requirements , always remain faithful , Diligence 、 Perform duties independently ， Actively attend the company 202 5 Annual Related Meetings , Carefully consider the proposals of the board of directors ， Give full play to the role of independent directors ， Effectively safeguard the interests of the company and all shareholders, especially small and medium-sized shareholders 。 Now Just me 202 The performance of duties in the 5th year is as follows:
-
Basic information of independent directors Huang Tao, Ph.D., is currently a researcher and doctoral supervisor at Guanghua Law School of Zhejiang University, and also serves as an innovation officer Independent director of Medical Management Co., Ltd. and Zhejiang Zhaosheng Technology Co., Ltd. From October 2025 to the present, Served as an independent director of the company. During the reporting period, I conducted a self-examination of my independence and believed that I did not have any impact on my independence meets the independence requirements stipulated in Article 6 of the Measures for the Administration of Independent Directors of Listed Companies.
-
Attendance at the Board of Directors and Shareholders' Meetings 2025 Annual , I am an independent director of the company , in strict accordance with the law 、 Requirements for Regulations and Rules and Regulations ， Diligent performance of duties , There is no absence of attending the meeting 。 2025 Annual ， During my tenure, the company has a total of Planned 2 Board of Directors 、 1 Sub-shareholders' Meeting , The convening of the board of directors and shareholders' meetings is in accordance with legal procedures , Major Business decision-making matters and other major matters have been carried out in relevant procedures ， Legal and valid 。 2025 My Personal to Public